2024 annual financial data
TG Therapeutics 2024 Net margin
Direct answer
Net margin was 7.11%.
Operating income was 41,929,000 USD and net income was 23,383,000 USD.
Operating cash flow was -40,517,000 USD.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 329,004,000 USD
- Operating income
- 41,929,000 USD
- Net income
- 23,383,000 USD
- Operating cash flow
- -40,517,000 USD